Obstructive sleep apnea (OSA) patients' consistent use of continuous positive airway pressure (CPAP) therapy is critical to realizing improved functional outcomes and reducing untoward health risks associated with OSA. We conducted a mixed methods, concurrent, nested study to explore OSA patients' beliefs and perceptions of the diagnosis and CPAP treatment that differentiate adherent from nonadherent patients prior to and after the first week of treatment, when the pattern of CPAP use is established. Guided by social cognitive theory, themes were derived from 30 interviews conducted postdiagnosis and after 1 week of CPAP use. Directed content analysis, followed by categorization of participants as adherent/nonadherent from objectively measured CPAP use, preceded across-case analysis among 15 participants with severe OSA. Beliefs and perceptions that differed between adherers and nonadherers included OSA risk perception, symptom recognition, self-efficacy, outcome expectations, treatment goals, and treatment facilitators/ barriers. Our findings suggest opportunities for developing and testing tailored interventions to promote CPAP use.
adherence rates ranging from 30% to 60% (Engleman, Martin, & Douglas, 1994; Kribbs et al., 1993; Krieger, 1992 ; Reeves-Hoche, Meck, & Zwillich, 1994; Sanders, Gruendl, & Rogers, 1986; Weaver, Kribbs, et al., 1997) . Nonadherent users begin skipping nights of CPAP use during the first week of treatment, and their hourly use of CPAP on days used is significantly shorter than those who apply CPAP consistently Weaver, Kribbs, et al., 1997) . Patients who are nonadherent during early treatment generally remain nonadherent over the long term Krieger, 1992; McArdle et al., 1999; Weaver, Kribbs, et al., 1997) . The return of symptoms and other manifestations of OSA with even one night of nonuse underscores the critical nature of adherence to CPAP (Grunstein et al., 1996; Kribbs et al., 1993) .
Many studies have explored what factors predict adherence to CPAP (Engleman et al., 1996; Engleman, Martin, et al., 1994; Kribbs et al., 1993; Massie, Hart, Peralez, & Richards, 1999; McArdle et al., 1999; Meurice et al., 1994; Reeves-Hoche et al., 1994; Rosenthal et al., 2000; Schweitzer, Chambers, Birkenmeier, & Walsh, 1997; Sin, Mayers, Man, & Pawluk, 2002) . Selfreported side effects of CPAP do not distinguish between adherers and nonadherers to CPAP. Subjective sleepiness, severity of OSA as determined by apnea-hypopnea index, and severity of nocturnal hypoxia are inconsistently identified as correlates, albeit weak, of CPAP adherence (Weaver & Grunstein, 2008) . The majority of these studies have focused on physiological variables and patient characteristics as predictors of adherence. Over the past 10 years, studies have identified psychological and social factors and cognitive perceptions, such as selfefficacy, risk perception, and outcome expectancies, as determinants of CPAP use (Aloia, Arnedt, Stepnowsky, Hecht, & Borrelli, 2005; Lewis, Seale, Bartle, Watkins, & Ebden, 2004; Russo-Magno, O'Brien, Panciera, & Rounds, 2001; Stepnowsky, Bardwell, Moore, Ancoli-Israel, & Dimsdale, 2002; Stepnowsky, Marler, & Ancoli-Israel, 2002; Wild, Engleman, Douglas, & Espie, 2004) . Social and situational variables have also been suggested as influential on CPAP adherence, with those who live alone, who have had a recent life event, and who experienced problems with CPAP on the first night of exposure having lower adherence to CPAP therapy (Lewis et al., 2004) . Support group attendance has also been identified as contributing to higher CPAP use in older men (Russo-Magno et al., 2001) . Findings of both of these studies suggest that social support is an important factor influencing decisions to use CPAP, yet the sociostructural context of accepting and adhering to CPAP treatment has not been described from the perspective of the patient in the extant literature. Other studies have identified that early experiences with CPAP (i.e., during the first week) are an important influence on patients' perceptions and beliefs about the OSA diagnosis and treatment with CPAP (Aloia, Arnedt, Stepnowsky, et al., 2005; Stepnowsky, Bardwell, et al., 2002) .
From the collective published evidence, early experiences with CPAP, combined with patients' perceptions and beliefs about OSA and CPAP and the balance of their sociostructural facilitators/barriers, are critical factors that influence patients' decisions to use CPAP. To date, there are relatively few studies that have systematically examined the influence of disease and treatment perceptions and beliefs on CPAP adherence. Because the first week of CPAP treatment is critically influential on OSA patients' decisions to use CPAP, it is imperative that the contextual experiences and underlying beliefs and perceptions of the diagnosis and treatment be described. There are no published studies that have addressed this significant gap in the scientific literature. Furthermore, no study has directly explored patient perspectives, employing qualitative methodology, both at diagnosis and with treatment, to more fully describe contextual factors that differentiate CPAP adherers and nonadherers. Our study addressed several important questions: (a) What are adult OSA patients' beliefs and perceptions about OSA, the associated risks, and treatment with CPAP prior to treatment use? (b) What are the consequences of these beliefs and perceptions on the use of CPAP? (c) What are the beliefs and perceptions of adults with OSA after 1 week of CPAP use, including perceived benefits of treatment, effect of treatment on health, and perceived ability to adapt to CPAP? and (d) Do differences exist between adherers and nonadherers with regard to their beliefs and perceptions at diagnosis and with treatment use that might, in part, explain differences in CPAP adherence outcomes? To our knowledge, our study findings provide the first published description of beliefs of those who adhere and those who choose not to adhere to CPAP treatment. These findings contribute to understanding patient treatment decisions regarding CPAP use, suggest opportunities for identifying those at risk for nonadherence to CPAP, and contribute toward developing tailored interventions to promote CPAP use.
Conceptual Framework
Acceptance and consistent use of CPAP is influenced by a multitude of factors, as is evidenced in previous studies examining predictors of CPAP adherence (Weaver & Grunstein, 2008) . It is therefore important to approach the phenomenon of CPAP adherence from a multifactorial perspective that addresses the complex nature of this particular health behavior. The application of social cognitive theory has been widely applied in studies of adoption, initiation, and maintenance of health behaviors (Bandura, 1977 (Bandura, , 1992 Schwarzer & Fuchs, 1996) . The core determinants of the model include knowledge, perceived self-efficacy, outcome expectations, health goals, and facilitators/barriers. The model posits that healthpromoting behaviors are primarily influenced by patients' self-efficacy, or their belief in their ability to exercise control over personal health habits, which influences other critical determinants: knowledge, outcome expectations, goals, and perceived facilitators and impediments (Bandura, 2004 ; see Figure 1 ). Knowledge of health risks and specific benefits relative to health behaviors is a necessary determinant for health behaviors, but rarely does knowledge alone promote change in behaviors. Outcome expectations, or the expectancies one holds for investing in a particular health behavior, are evaluated by the individual in terms of costs and benefits, including physical, social, and psychological. Individuals who anticipate that the benefits of a health behavior outweigh the costs are more inclined to perceive the health behavior as favorable, and more inclined to set short-and long-term personal goals to guide adoption of that health behavior. This cascade of health behavior determinants does not occur in isolation, but is influenced by barriers and facilitators that derive from personal, social, and environmental circumstances. As individuals identify facilitators for the health behavior and overcome barriers, their belief in their ability to successfully change or adopt a health behavior (i.e., perceived self-efficacy) increases.
Recognizing that individuals exist within a collective agency or community, the construct of self-efficacy is not confined solely to personal capabilities. Although commonalities in the basic concepts of self-efficacy exist across cultures, the "cultivated identities, values, belief structures, and agentic capabilities are the psychosocial systems through which experiences are filtered" (Bandura, 2002, p. 273) . Bandura suggested that the application of social cognitive theory must be situated in context, recognizing that "human behavior is socially situated, richly contextualised, and conditionally expressed" (2002, p. 276) . From this conceptual perspective and in a predominantly qualitative research paradigm, we examined patients' perceptions, beliefs, and experiences within their own context to permit an explicit description of salient factors that influenced OSA patients' decisions to use or not use CPAP.
Method Design
Using a concurrent nested, mixed method design, we conducted a longitudinal study extending from initial diagnosis through the first week of home CPAP treatment of newly diagnosed OSA patients. We conducted two individual interviews with participants and collected first-week CPAP adherence data. In contrast to a triangulation design, the concurrent nested study design emphasizes one methodology, and the data are mixed at the analysis phase of the study (Creswell, Plano Clark, Gutmann, & Hanson, 2003) . Nesting the less dominant quantitative method within the predominant qualitative method permitted an enriched description of the participants and a more in-depth analysis of the overall phenomenon of interest: CPAP adherence (Creswell et al., 2003) .
Participants
Adults with suspected OSA were recruited from a sleep clinic at an urban Veterans Affairs medical center during a 5-month enrollment period. One sleep specialist referred potential participants who were clinically likely to have OSA to the study. Our purposive sampling strategy was to Figure 1. Social cognitive theory health determinants: Pathways of influence of self-efficacy on health behaviors. From Bandura, A. (2004) . Health promotion by social cognitive means. Health Education & Behavior, 31(2), 146. Copyright 2004 by Sage Publications. Reprinted with permission of the publisher.
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Goals Behavior include patients who (a) provided detailed information during their initial clinical visit and were willing to openly discuss their health and health care; (b) had at least moderate OSA (AHI ≥ 15 events/hour; American Academy of Sleep Medicine Task Force, 1999) and were prescribed CPAP treatment; (c) initially accepted CPAP for home use; and (d) were able to speak and understand English. To ensure that participants would be prescribed CPAP treatment based on Veterans Health Administration CPAP prescribing guidelines in place during study enrollment, patients with mild OSA (AHI < 15 events/hour) were excluded. We also excluded participants who had current or historical treatment with CPAP or any other treatment for OSA, a previous diagnosis of OSA, refusal of CPAP treatment by the participant prior to any CPAP exposure (i.e., in-laboratory CPAP titration sleep study), and those who required supplemental oxygen in addition to CPAP and/or bilevel positive airway pressure therapy for treatment of sleep-disordered breathing during their in-laboratory CPAP titration sleep study. Previous studies have identified that decisions to adhere to CPAP emerge by the second to fourth day of treatment Weaver, Kribbs, et al., 1997) . Therefore, it is possible that patients' beliefs, perceptions, and experiences during the first several experiences with CPAP might significantly influence short-and long-term CPAP adherence patterns. For this reason, we did not include individuals who refused CPAP treatment prior to any CPAP experience, because we sought to describe salient factors preceding and during initial CPAP exposure. The protocol was approved by the research site and the affiliated university's institutional review boards. All participants provided informed consent prior to participating in any study activities.
Procedure
After study enrollment, each participant had two inlaboratory, full-night sleep studies (i.e., polysomnograms). The first sleep study was a diagnostic study and the second sleep study was to determine the therapeutic CPAP pressure necessary to eliminate obstructive sleep apnea events. All sleep studies were performed and scored using standard criteria (American Academy of Sleep Medicine Task Force, 1999; Rechtschaffen & Kales, 1968) . The AHI, a measure of disease severity in OSA, was computed from the diagnostic polysomnogram as the number of apneas and/or hypopneas per hour of sleep. The therapeutic CPAP pressure, the pressure required to eliminate hypopneas and apneas, was determined on a manual CPAP titration polysomnogram performed about 1 week (7.9±6.9 days) after the diagnostic polysomnogram.
Semistructured interviews. Semistructured interviews, conducted by one study investigator, were scheduled with participants at two intervals: within 1 week following diagnosis but prior to the CPAP titration sleep study, and after the first week of CPAP treatment at home (see Figure 2 ). All interviews were conducted in an informal, private room at the medical center to ensure privacy, participant comfort, and promote open sharing of information (Streubert Speziale & Carpenter, 2003) . To minimize attrition, participants were offered the opportunity to participate in interviews at an alternative location or by telephone if transportation difficulties or ambulatory limitations precluded study participation.
Interview guides, consisting of specific questions and probes (i.e., prompts to encourage focus on the particular issue of interest) were used for each interview to ensure that a consistent sequence and set of questions were addressed across participants. A funnel approach was used in the development and execution of the interview guides. This approach begins with broad questions and gradually progresses to focused questions specific to the phenomenon of interest to promote sharing of experiences by the participants (Tashakkori & Teddlie, 1989) . The first interview focused on perceptions of the diagnosis, perceived health effects of the diagnosis, pretreatment perceptions of CPAP, and the social and cultural precedents that led to the participant seeking medical care for their sleep problems (see Table 1 ). The second interview focused on perceived effects of treatment with CPAP, supportive mechanisms or barriers to using CPAP, and how beliefs and perceptions about the diagnosis, associated risks of the diagnosis, and the treatment experience might have affected CPAP adherence (see Table 2 ). Interviews were digitally audio-recorded and transcribed to an electronic format by a professional transcriptionist not affiliated with the study. Field notes were maintained by the interviewer before and after each interview to describe the environment of the interview, describe the participant at the time of the interview, and note any aberrations from the planned interview guide that occurred and a description of such aberrations. The field notes not only served as a descriptive context of the interview, but also served as interviewer reflexivity notations (i.e., interviewer biases, suppositions, and presuppositions of the research topic).
The purpose of maintaining reflexivity notations was to ensure that interviewer-imposed assumptions did not take precedent over the participant's described experience.
CPAP adherence. In accordance with the standard of clinical care at the sleep center, all participants were issued the same model CPAP machine (Respironics Rem-Star Pro®) that records on a data card (SmartCardTM) the time each day that the CPAP circuit is pressurized, an objective measurement of daily CPAP mask-on time. CPAP use was defined as periods when the device was applied for more than 20 minutes at effective pressure. One week of CPAP adherence data were uploaded to a personal computer for software analysis (Respironics EncorePro®) at the time of the second semistructured interview. Graphic adherence data were used as probes to discuss specific occurrences of CPAP nonuse. The objectively measured CPAP adherence data were also used to identify adherent (≥ 6hrs/night CPAP use) and nonadherent participants (< 6hrs/night CPAP use). A cut-off point of 6 hours/night was selected a priori to describe adherers and nonadherers to CPAP treatment, as recent evidence suggests that 6 or more hours of CPAP use per night is necessary to improve both functional and objective sleepiness outcomes (Weaver et al., 2007) .
Analysis
A sequential analysis was conducted, with qualitativedirected content analysis of interview data followed by quantitative descriptive analysis of the CPAP adherence data. By sequentially analyzing the data, the priority of the individual as informant was emphasized and the investigators were blinded to CPAP adherence until the final analysis procedure, a mixed methods analysis, was conducted (see Figure 3 ). By dividing the participants into categories of adherent (i.e., ≥ 6 hrs/night CPAP use) and nonadherent (i.e., < 6 hrs/night CPAP use), we examined across-case consistencies in subthemes and themes to describe the contextualized experience of adhering or not adhering to CPAP treatment. Each transcript was read in its entirety, highlighting, extracting, and condensing text from individual interviews that addressed individual beliefs, perceptions, and/or experiences during diagnosis and early treatment with CPAP. This process of text analysis brought forward the manifest content of the qualitative data (Graneheim & Lundman, 2004) . These responses were separated from the interview text, identified by participant identification number, and entered into an analysis table. Abstraction, or the process of taking condensed, manifest data and interpreting the underlying meaning (i.e., latent meaning), followed as participant responses were then described in a condensed format and interpreted for meaning within a thematic coding process. Trustworthiness was enhanced as the likelihood of investigator bias was minimized by first highlighting relevant text for coding, extracting relevant text from complete interviews transcripts, and then coding the meaning units for theory-driven categories or themes and then for subthemes (Hsieh & Shannon, 2005) .
The overarching, theory-derived themes were initially determined by applying the broad determinants of health as described in the study's conceptual framework, social cognitive theory (Bandura, 2004) . These themes included knowledge, perceived barriers and facilitators, perceived self-efficacy, outcome expectations, and goals. This approach permitted the investigators to examine the applicability of the theoretical framework to the phenomenon of CPAP adherence and elaborate on previous findings suggesting the framework's concepts as measurable predictors of CPAP-related health behaviors (Aloia, Arnedt, Stepnowsky, et al., 2005; Stepnowsky, Bardwell, et al., 2002; Wild et al., 2004) . Emergent subthemes were identified as thematic content analysis progressed. The subthemes were then categorized within the overarching conceptual framework themes (see Table 3 ). We designed the analysis strategy to be consistent with other recent empirical studies of CPAP adherence while permitting a more robust, narrative description of what these theoretically derived variables mean from the perspective of the OSA patient. Theme definitions were developed by the investigators and reviewed by an expert qualitative methodologist and an expert in the research application of theoretical constructs. One study investigator, blinded to CPAP adherence data, coded all interview data for the study. Valid application of the themes was examined by an independent expert coder. Coded interviews were independently recoded by the expert coder to establish validity and reliability of the application of the codes to the interview data. All extracted interview data were eligible for recoding; approximately 15% of the data from each total interview were randomly selected for expert recoding. Agreement of the study coder and the expert coder was 94%, meeting the established criteria of 80% agreement for acceptance of the coded data. When differences in application of codes were identified, code definitions were reviewed by coders, discussion of specific application of the code(s) was held, and mutual agreement was achieved in all instances of coding differences.
After all interview data were coded for themes, the investigators used the average daily CPAP use during the first week of treatment to separate adherers (≥ 6 hours CPAP use/night) and nonadherers (< 6 hours CPAP use/ night). Descriptive statistics were used in the analysis of 1 week of CPAP adherence data (mean ± standard deviation [SD]). Across-case analysis of themes and subthemes was then examined from an integrative perspective, using adherent and nonadherent as anchors, or as a unique descriptive qualifier, to identify common perceptions, beliefs, and experiences within the groups of interest. The Knowledge and information provided to individual and applicability of information influences individual's assumption of responsibility for OSA and CPAP treatment Early response to CPAP, consistent or inconsistent with outcome expectations, facilitates or is a barrier to treatment use Early experience with CPAP is a source of support or a barrier to belief in own ability to use treatment Fitting treatment into life Problem-solving difficulties/routinization of CPAP responsibilities contribute to disease management Outcome expectations Understanding why symptoms exist and associating specific symptoms with a diagnosis provides hope that treatment will address experienced symptoms and improve overall quality of life Expectations of treatment outcomes are facilitators of treatment initiation and use Early response to CPAP, consistent or inconsistent with outcome expectations, facilitates or is a barrier to using treatment Goals Problem-solving difficulties/routinization of CPAP responsibilities contribute to disease management a Themes derived from participant text data were categorized as a determinant of health behavior from social cognitive theory. Themes are not mutually exclusive. Theme definitions were mutually agreed on by investigators of the study and applied to the directed content analysis procedure by a single investigator acting as the primary coder of text data.
across-case analysis, including both qualitative and quantitative data sets as complementary within an analysis matrix, gave rise to cases that had common descriptive aspects.
Results
With the recurrence of themes in the content analysis phase, data saturation was reached at 15 participants and the sampling procedure was considered complete. The participants were all veterans, predominantly middleaged (53.9 ± 12.7 years) men (88%; see Table 4 ). The participants were well educated, with 93% (n = 14) of the sample achieving a high school education or higher. The sample, on average, had severe OSA (AHI 53.5 ± 26.5 events/hr), with an oxygen nadir of 66.4% (± 13.2%). The average CPAP pressure setting was 10.7 ± 1.6 cmH20. Average CPAP use during the first 7 days of CPAP treatment was 4.98 ± 0.5 hours/night. Sorting on CPAP adherence (i.e. ≥ 6hrs/night CPAP use and <6 hrs/ night CPAP use), there were six adherers and nine nonadherers. The interview prior to CPAP exposure was conducted after the diagnostic polysomnogram, on average at Day 9 (range 2 to 28 days), and the second interview was conducted following at least 1 week of CPAP treatment (average number of days from Day 1 of CPAP use, 18; range 7 to 47 days).
Adherers and Nonadherers to CPAP Therapy
Knowledge and perceived health risks. Knowledge, or the "knowing" an individual has about the health risks and benefits of health behaviors (Bandura, 2004 ) was a predominant theme in both interviews for all participants. Saturation on nearly every knowledge theme suggests that participants identified that having an understanding of OSA and CPAP is an important part of the experience of being diagnosed with OSA and treated with CPAP. Adherent participants related their knowledge of risks and benefits of CPAP to their own outcome expectations after being diagnosed with OSA. For some participants, knowledge of OSA being simply more than snoring was a first step in recognizing OSA as a syndrome with health implications. One participant described this, saying, "I knew sleep apnea existed, but it just never dawned on me how serious it was in my case. I just didn't pay any attention to it. I just figured I was going to snore for the rest of my life." For many participants, "putting the whole picture together" after receiving education about OSA and CPAP treatment helped them understand that they not only were experiencing symptoms of OSA on a daily basis, but their overall health and quality of life was impacted by OSA. During the first interview, participants were provided with a summary of their diagnostic sleep study results. The combination of education about the OSA diagnosis and treatment with CPAP, and relating their own diagnosis to their daily health and functioning, was important to adherent participants' formulation of accurate beliefs and perceptions of OSA and CPAP. These beliefs served to motivate or facilitate adherent participants' determination to pursue CPAP after diagnosis: I didn't know anything really, how the CPAP worked or anything like that. I just knew that there was a disease called sleep apnea and that a lot of people have it and people don't realize it. I really still didn't know anything about it til after I went through the test [diagnostic polysomnogram]. . . . Five [breathing events] is normal and thirty is severe and I'm doing ninety an hour. You know that literally scared the hell right out of me because all I could think of is I'm going to die in my sleep. For many adherent participants, knowledge of health risks associated with OSA was limited to "being sluggish" or "having low energy levels." For some, their perception of OSA was only relative to "falling asleep when I sit down." Participants who "put the whole picture together," relating their diagnosis to their own health status, were motivated to accept CPAP treatment from the outset. For example, one participant said, "It's [OSA] got to take a toll in the long run on a lot of things, like high blood pressure. I'm hoping that it helps me to drop my high blood pressure." These perceptions provided hope for adherent participants that expanded beyond the management of their OSA to other disease and health experiences:
If I have more energy and I'm not so sluggishbecause I go to the local high school track and get in five or six laps, walking around the track-I will have more energy to do those kinds of things that keep you healthy.
Posttreatment, there was less emphasis on knowledgebased themes among adherent participants. This suggested a shift of emphasis among adherers from knowledge of risks and benefits of OSA to perceptions derived from the actual experience of CPAP treatment.
Nonadherent participants' knowledge at diagnosis was not different from adherent participants' knowledge. However, those with knowledge that served as a barrier, rather than a facilitator, to diagnosis were less likely to pursue a diagnostic sleep study in a timely fashion. This was particularly true for those who had inaccurate knowledge and perceptions of OSA, such as OSA being a condition of simple snoring. Even though many acknowledged they probably had OSA, the snoring was the "problem" that defined OSA, not apneic events and resultant untoward health and functional outcomes. As one participant described, Furthermore, describing early knowledge of "having to wear a mask" for the treatment of OSA served as a barrier to both seeking diagnosis and treatment for some. This perception was not consistent among only nonadherers though, as many of the participants expressed concerns about the anticipated treatment of their OSA. CPAP adherers and nonadherers described critically important differences in their own ability to reconcile the following: (a) their OSA diagnosis; (b) their experience of symptoms; (c) their goals for treatment use; and (d) their outcome expectations that were met after treatment exposure. These factors, when reconciled by the individual, facilitated overall positive perceptions of the diagnosis and treatment experience.
Goal setting and outcome expectancies. Outcome expectancies are the expected or anticipated costs and benefits for healthful habits/behaviors that support or deter from an individual's investment in the behavior (Bandura, 2004) . Among the participants, postdiagnosis outcome expectancies that were consistently met were highly influential on participants' decisions to use CPAP. For example, after being diagnosed with OSA, one participant brought all his experienced symptoms into perspective, relating them to his OSA. With treatment, he was hopeful that these symptoms would resolve. He stated, "It seems like sleep apnea basically causes all those problems. So I figure if I can get this taken care of [by wearing CPAP], basically the problems will subside." Making sense of symptoms in terms of treatment outcome expectancies helped adherers commit to trying CPAP and believing that CPAP was going to be a positive experience. One participant summarized his perception of symptoms and outcome expectations like this: "But without me even trying it I know that what I'm experiencing and how it's affected me, and that I want to get better if I can and so there's nothing going to keep me away from getting a CPAP." A particularly important perception described by participants was their early response to CPAP as influential on future/continued use of CPAP. These early, first experiences were helpful to formulating realistic and personally important outcome expectancies for CPAP use. One participant described his response to CPAP after wearing it for the first time in the sleep laboratory during his second sleep study (i.e., CPAP sleep study):
But being like I got relief the first night I was at the hospital. I drove home that morning after they woke me up, I went down, I got breakfast, and I'm driving home, I'm saying to myself, gee, I feel great and I only got from one o'clock to six, you know. I feel so much better and I felt so much better that whole day. I felt so good after that five hours of sleep with the machine on that it sold me.
For adherent participants, having a positive response to CPAP during the sleep study night with CPAP was highly motivating for continued CPAP use at home. Furthermore, this early response set the stage for participants to develop an early commitment to the treatment, even when faced with barriers. Persistent, positive responses to CPAP throughout the early treatment period (i.e., 1 week) reinforced participants' outcome expectancies and helped them formulate a perception of the treatment that was conducive to long-term use.
Goals for improved health and for achieving certain health behaviors are an important part of being successful with any health behavior. According to Bandura (2004) , individuals set goals for their personal health, including establishing concrete plans or strategies for achieving those goals. Goal setting among adherent CPAP users focused on "how best to adapt to using CPAP" or identifying "solutions to difficulties with use of CPAP." These goals were established so that adherent CPAP users were able to achieve their outcome expectations. Goal setting was not specifically discussed by adherent participants before using CPAP. With exposure to and experience with CPAP, adherent participants first identified that using CPAP was important and, thereafter, identified "tricks and techniques" to successfully use CPAP. Whether these strategies originated from the participant or were a collaborative effort between participant and a support source, having a plan that addressed how best to adapt to CPAP promoted continued effort directed at using CPAP, as described by one adherent participant: I guess the first night I put it on I sort of got a little feeling of claustrophobia, but I pushed it out of my mind, saying to myself, "Don't let this [bother you], this is a machine that is going to help you, you got to wear it," so I just put it in my mind that I was going to wear it.
As this participant described, it was important for him to devise a way that he could use the treatment so that he might realize his overall health goals. Similarly, one participant found that he could not fall asleep with CPAP at full pressure. He emphasized the importance of using CPAP to treat his OSA, but he equated using CPAP to "a tornado blowing through your nose." He recalled being taught about several features on the CPAP machine that might alleviate this sensation. After testing a few tricks on the CPAP machine, he found that he was able to fall asleep on a lower pressure setting while the pressure increased to full pressure setting after he was asleep (i.e., ramp function). By setting an immediate goal to get to sleep while wearing CPAP, he was able to achieve his longer-term goal to wear CPAP each night. The longterm goal of adherent participants was to feel better or sleep better, but the immediate goal was to be able to wear CPAP.
For nonadherers, a negative experience during their CPAP sleep study led them to have an undesirable outlook on CPAP and the overall treatment of OSA. For example, one participant described experiencing no immediate response to CPAP during the CPAP sleep study; therefore, he didn't expect to experience any response to treatment over a more extended period of time:
I still had the same kind of sleep, I thought. As a matter of fact I thought it took me longer to get to sleep than it did on the first sleep study [without CPAP]. I believe my sleep was still the same type of sleep that I always get, even though, you know, the machine was supposed to make me sleep better. I still woke up in the same condition that I usually wake up in, is what I'm trying to say. I didn't feel any more vigorous or alert or anything after that first night.
Participants' descriptions of their considerations for using CPAP consistently included the question, "What are the down sides of using CPAP?" Combining early negative perceptions of the treatment and early negative experiences with CPAP, nonadherers tended to see the drawbacks of using the treatment as far outweighing any benefits of using the treatment. One participant described both negative perceptions and negative experiences, which caused him to believe that CPAP treatment outcome expectancies were not worth the torment of using the treatment:
No, I didn't think I couldn't do it from the beginning. I was believing it was gonna do something more than what it did, and it didn't do anything. I'm not getting sleep, I'm still getting up tired. I guess I expected more from it and I didn't get anything, not anything that I could see anyway. No, just a bunch of botheration and I didn't get any sleep.
Among participants who did not adhere, the goaloriented theme was not present after diagnosis.
Nonadherers did not articulate specific goals for attaining treatment and, furthermore, they did not describe strategies to be able to wear CPAP after 1 week of CPAP treatment. For nonadherers, establishing treatmentrelated goals for use of CPAP was not a priority.
Facilitators of and barriers to CPAP use. Perceived facilitators and barriers can be personal, social, and/or structural. Although perceived facilitators and barriers are influential on health behaviors, this process is mediated by self-efficacy (Bandura, 2004) . Therefore, the existence of a barrier, in and of itself, might not be particularly influential on an individual's behavior if their self-efficacy is high. Consistent with this conceptual perspective, some participants identified barriers that were particularly troublesome when using CPAP, but were vigilant users of CPAP despite these barriers. Conversely, those who described numerous facilitators to using CPAP treatment were not necessarily adherent to CPAP.
Adherent participants were less focused on potential or actual facilitators and barriers to using CPAP over time than nonadherers. When adherent participants discussed facilitators and barriers, their overall descriptions were positive, with facilitators being the focus of their experience after using CPAP for 1 week. No adherent participants emphasized barriers to using CPAP after 1 week of treatment. Furthermore, when faced with barriers, adherent participants described perceptions of the treatment as important and identified a belief in their ability to overcome the barrier. For example, one participant experienced a sensation of not being able to breathe during his second night of CPAP use at home, but his ability to use CPAP was influenced by his commitment to "needing" the treatment:
Because it was like I couldn't breathe and even though the machine was on, it was like I was paralyzed, and this happened every time when I tried to go back to sleep. How many times? Three more times that very same night until I was getting really anxious because every time I would try to go to sleep, after a while I would get that anxiety again. Finally, I prayed. I got up and I prayed real hard, asked God to really help me with this and I was right to sleep. Ever since then, I pray every night and have no problems.
As this example demonstrates, barriers and facilitators are not independent determinants of health behavior. Participants described situations and experiences that were labeled as either a facilitator or barrier, but the actual behavioral outcome of getting to diagnosis and using CPAP was not necessarily reflective of such experiences being a barrier or facilitator.
The facilitating experiences described by adherent participants centered on social interactions that provided motivation and facilitation of their CPAP use. Facilitating experiences included descriptions of social support, shared experiences of CPAP use with other CPAP users, and recognition that their own improvement as a result of CPAP treatment was an important influence on social relationships. Social relationships and the ability to be fully engaged in social interactions during their first week of CPAP use was described by several adherent participants as a facilitator to ongoing treatment: I see the difference. People see the difference. My wife sees the difference. My kids see the difference. That helps. I think that's 50% of it. People telling you that you have changed and things are getting better and you look a lot better and you a sound a lot better and you act a lot better, because when you have feedback like that you know it's [CPAP] helping.
Our relationship [with spouse] is getting better and better. I think since the sleep machine it's even been more because some things that irritate me, I would speak on and it would cause like a little bit of friction, as it happens in couples. But since I've had the sleep machine, I've been letting the minor things go, things that irritate me or I would complain about before. . . . Communication, our relationship, so we've been able to talk more and enjoy each other even more since then [starting CPAP]. Yeah, I like the machine, I really do, and I like what it's doing.
Adherent participants clearly emphasized the importance of improved social relationships as a result of their CPAP treatment. Many recognized such improvements after a close friend or family member suggested the improvement was obvious.
Nonadherent participants emphasized barriers rather than facilitators to using CPAP after being diagnosed with OSA. However, after using CPAP for 1 week, nonadherers identified few, if any, actual barriers to treatment. Unlike adherent participants, nonadherers did not discuss social interactions as an important part of their post-CPAP treatment experience. Nonadherent participants also identified themselves as single, divorced, or widowed, with the exception of one participant. Nonadherers did not discuss their social networks (i.e., friends, family outside of their residence, coworkers) as important to their experiences of being diagnosed with OSA and starting CPAP treatment.
Perceived self-efficacy. Perceived self-efficacy is the belief that one can exercise control over one's own health habits, producing desired effects by one's own health behaviors (Bandura, 2004) . This overarching theme was meaningfully described by participants and represented by several subthemes that were important to both adherers and nonadherers in the study. Within these descriptions, participants offered experiences with being diagnosed with OSA and using CPAP that led to their belief in themselves, or lack thereof, to use or not use the treatment. Adherers in the sample described generally positive perceived self-efficacy regarding future use of CPAP. Adherers had a positive belief in their ability to use CPAP from the outset, which persisted and became increasingly frequent from diagnosis to early CPAP treatment, even if they first doubted their ability to use the treatment. As one participant described, the first thought of wearing a mask during sleep was not appealing, but with a positive first experience with CPAP, the participant was increasingly confident that CPAP was going to be a part of his life:
I think I seen the masks sitting there and I thought to myself, I hope I don't have to wear one of those things. Then they came in and said, "Now we're going to put the CPAP on you," and I said, "Okay," and they put the CPAP on me and when they came back into the room I felt great when I woke up at six. They had to wake me up at six o'clock because I was sleeping and you know, I think I felt after that, I didn't care what it was if I got that much sleep from one o'clock to six without getting up. I was going to wear or do whatever I had to do to do it [wear CPAP].
Adherent participants also described that they planned to incorporate CPAP into their daily routine, suggesting an underlying positive belief in their ability to accomplish the health behavior of using CPAP. Recognizing that using CPAP would necessitate additional daily "work," adherers had well-defined plans of incorporating the added demands to their daily schedule: I have to just add some things that I have to do in order to keep the CPAP machine clean and to make sure that it's dry and each week I have to disinfect it, but once I did it, once I decided I was gonna do it, I just went in the bathroom, did the whole thing, it only took about twenty minutes, twenty-five minutes, and I was all done. And getting up in the morning and doing the daily cleaning, you know, that's not a negative but it's just something I have to make an adjustment to. Nonadherent participants described having largely negative experiences with CPAP during the first exposure (i.e., CPAP sleep study) or during the early phase of home CPAP use. Few nonadherent participants experienced benefits with treatment and nonadherers described unsuccessful or a lack of problem-solving efforts with CPAP difficulties. These negative experiences were important areas of concern with regard to their perceived ability to use CPAP over the long term (perceived selfefficacy). For example, one participant had such an extremely negative experience during the first week he was exposed to CPAP that he firmly doubted his ability to ever use it: I couldn't breathe in [the mask]. This thing, I had to suck in to get a breath out of it. Last night I got a good night's sleep but I woke up, then I was claustrophobic. I felt like I was stuck under a bed someplace and couldn't get out and then I woke up. When I wore it the whole night through I wasn't sleeping so that's one of the reasons [I won't use CPAP], like I didn't sleep with it on; it was too aggravating.
Each participant described getting used to CPAP during the first several nights of treatment. With unsuccessful experiences during this period, participants either identified resources to help improve their experience or made decisions to use CPAP less or not at all. For all participants, early experiences with CPAP contributed to their belief in their own abilities to get used to the therapy.
Individuals who had difficulty fitting CPAP into their lives were challenged to be adherent to the treatment. When CPAP was seen as not fitting into a life routine, participants offered doubts as to their ability to continue to use the treatment. One participant described having a routine of falling asleep with television. With CPAP, she had difficulty watching television and therefore she experienced more difficulty getting to sleep. Although she continued to try to use CPAP, she expressed that using CPAP was generally annoying to her. The complexities presented by using CPAP within the constraints of her normal routine were likely to increasingly influence doubt in her ability to use CPAP.
Married and Unmarried CPAP Users
With the emerging emphasis placed on social support and social networks by adherers in the study, we explored how the social context of daily life impacted on perceptions of OSA and CPAP treatment by examining married (n = 7) and unmarried (n = 8) participants' responses. Using married and unmarried status from self-reported demographic characteristics as anchors, or as a unique descriptive qualifier, we sorted the subthemes within an analysis matrix to identify common perceptions, beliefs, and experiences within these qualifier groups. We included all participants who identified themselves as married or common-law married as married; all participants who identified themselves as single, divorced, or widowed were included as unmarried.
These groups described different experiences with both diagnosis and CPAP treatment. Married participants offered descriptions of social support resources within immediate proximity that were positive facilitators of seeking diagnosis and starting/staying on treatment. Married participants expressed positive beliefs in their ability to use CPAP with early treatment use, often described in conjunction with a CPAP problem-solving episode that was collaboratively resolved with their partner/spouse. Married participants described overwhelmingly positive early responses and experiences with CPAP treatment. Their outcome expectations were consistent across time. They generally anticipated positive responses to CPAP prior to exposure and experienced positive responses to treatment after 1 week of use. Married participants also identified success in "fitting CPAP into their lives." These participants were able to identify far more benefits from than difficulties with CPAP, benefits that enhanced their ongoing commitment to use of the treatment. Married participants discussed proximate support sources (i.e., spouse, living partner, family members) as important to providing feedback about their response to treatment, trouble-shooting difficulties, and positive reinforcement for persistent use of CPAP.
Unmarried participants commonly identified friends or coworkers as motivating factors (facilitators) to seek diagnosis but less social influence on/facilitation of treatment use after 1 week of CPAP therapy. Without the presence of immediate social support, unmarried participants did not emphasize important social interactions with actual wearing of CPAP. After 1 week of treatment on CPAP, unmarried participants described less confidence in their ability to use CPAP and described less "response" to CPAP than those participants who were married. Unmarried participants described few facilitators of treatment use during the first week of CPAP therapy. Nearly all unmarried participants identified "self-driven" reasons for pursuing treatment, and there was an absence of social sources of support, or "cheerleaders and helpful problem solvers" while using CPAP during the first week.
Typologies of Adherent and Nonadherent CPAP Users
Described differences in beliefs, perceptions, and experiences of being diagnosed with OSA and early treatment with CPAP were explicit between adherers and nonadherers. Adherers perceived health and functional risks of untreated OSA, had positive belief in their ability to use CPAP from early in the diagnostic process, had clearly defined outcome expectations, had more facilitators than barriers as they progressed from diagnosis to treatment, and identified important social influences and support sources for both pursuing diagnosis and persisting with CPAP treatment. Nonadherers described not knowing the risks associated with OSA, perceived fewer symptoms of their diagnosis, did not have clearly defined outcome expectations for treatment, identified fewer improvements with CPAP exposure, placed less emphasis on social support and socially derived feedback with early CPAP treatment, and perceived and experienced more barriers to CPAP treatment. As a result of the across-case analysis in which consistencies and differences emerged among adherers and nonadherers in the described experience of being diagnosed with OSA and treated with CPAP, we suggest typologies, or descriptive profiles, of persons with CPAP-treated OSA (see Table 5 ). The typologies we propose are consistent with previous empirical studies of CPAP adherence, in that predictive relationships between risk perception, outcome expectancies, perceived self-efficacy, and social support with CPAP use have been identified. Our study findings extend the previous findings by illuminating the importance of contextual meaning persons derive from their experiences, beliefs, and perceptions when progressing from diagnosis with OSA to treatment with CPAP. Moreover, the typologies succinctly describe critical differences between these groups of CPAP-treated OSA persons that support the development of patient-centered or -tailored adherence interventions that recognize individual differences.
Discussion
To our knowledge, this is the first study to apply a predominantly qualitative method to describe individuals' beliefs and perceptions of the diagnosis of OSA and treatment with CPAP relative to short-term CPAP adherence. Our findings are consistent with previous, empirical studies with regard to the overall applicability of social cognitive theory to the phenomenon of CPAP adherence. The findings from our study uniquely extend these previous findings by illuminating the importance of the individual experiences, beliefs, and perceptions as influential on decisions to pursue diagnosis and treatment of OSA. The described differences between adherers and nonadherers in our study suggest critical tailored or patient-centered intervention opportunities that might be developed and tested among patients who are newly diagnosed with OSA and anticipate CPAP treatment. The major findings of the study include the following: (a) adults described and assigned meaning to being diagnosed with OSA and treated with CPAP, which in turn influenced their decisions to accept or reject treatment and the extent of CPAP use; and (b) differences in beliefs and perceptions at diagnosis and with CPAP treatment were identified among CPAP adherers and nonadherers and also described in the social context of married and unmarried CPAP users. The described differences between these groups provide data to support the first published typology, or descriptive profile, of CPAP adherers and nonadherers.
Theoretically derived variables, such as the determinants of health behaviors described in social cognitive theory and applied in our study, are operational concepts that help us understand OSA patients' perceptions and beliefs about OSA and CPAP, and can guide interventions to improve adherence to CPAP. Framed by Bandura's social cognitive theory (1977) , differences among adherers and nonadherers to CPAP can be defined across social cognitive theory determinants of health behaviors: (a) knowledge, (b) perceived self-efficacy, (c) outcome expectancies and goals, and (d) facilitators and barriers. As previous studies have demonstrated, psychosocial constructs, such as those consistent with social cognitive theory, provide possibly the most explained variance, to date, among adherers and nonadherers (Aloia, Arnedt, Stepnowsky, et al., 2005; Engleman & Wild, 2003; Stepnowsky, Bardwell, et al., 2002; Weaver et al., 2003) . Furthermore, recent intervention studies to promote CPAP adherence have applied similar theoretical constructs with some positive findings Richards, Bartlett, Wong, Malouff, & Grunstein, 2007) . As our study findings suggest, decisions to use CPAP are individualized and at least in part dependent on the patient's support environment and early experiences with and beliefs about CPAP. Because early commitments to use or not use CPAP predict long-term use Weaver, Kribbs, et al., 1997) , it is critically important to understand and examine opportunities to intervene on factors that influence early commitments to use CPAP. This insight will potentiate the development of patientcentered and-tailored interventions to improve CPAP adherence at the individual level while collectively promoting the health outcomes of the OSA population.
Our study confirms that social cognitive theory is applicable to the unique health behavior of using CPAP treatment. Indeed, the interacting determinants of health as described by Albert Bandura (1977) in relationship to decisions to accept and use CPAP were clearly described by our study participants. This affirmation suggests that any one measured domain within the model (i.e., barriers, facilitators, outcome expectancies) is not likely to identify persons at risk for nonadherence to CPAP. Rather, our study findings support the complex and reciprocating nature of the theoretical model as it applies to this health behavior, and offer clarity to our understanding of CPAP adherence as a multifactorial, iterative decision-making process. It is therefore important to ascertain an understanding of the context of the individual from the initial diagnosis through early treatment use to address the complex nature of the problem of adherence to CPAP and to prospectively identify those likely to be nonadherent to the treatment.
In our study, the experience and perception of symptoms contributed to the participants' motivation to seek diagnosis and treatment and to adhere to CPAP treatment. Although studies that have examined pretreatment symptoms, particularly subjective sleepiness, have produced inconsistent results with regard to subsequent CPAP use, these studies have measured symptoms on quantitative scales that define specific scenarios of "impairment" related to the symptom of interest (i.e., Epworth Sleepiness Scale (Johns, 1993) , Functional Outcomes of Sleep Questionnaire (Weaver, Laizner, et al., 1997) , Stanford Sleepiness Scale (MacLean, Fekken, Saskin, & Knowles, 1992; Engleman et al., 1996; Hui et al., 2001; Janson, Describe barriers as more influential on CPAP use than facilitators Develop and define goals and reasons for CPAP use Facilitators of treatment absent or unrecognized Describe positive belief in ability to use CPAP even Describe low belief in ability to use CPAP with potential or experienced difficulties Proximate social influences prominent in decisions Describe early negative experiences with CPAP, reinforcing low belief in to pursue diagnosis and treatment ability to use CPAP Unable to identify positive responses to CPAP during early treatment Noges, Svedberg-Randt, & Lindberg, 2000; Kribbs et al., 1993; Lewis et al., 2004; McArdle et al., 1999; Sin et al., 2002; Weaver, Laizner, et al., 1997) . Yet, as our study highlights, perceptions of need relative to one's experience of symptoms were highly individual and significantly influenced decisions to pursue both diagnosis and treatment. Consistent with perceptions that influence medicine-taking behavior (Hansen, Holstein, & Hansen, 2009) , particular situations necessitated the pursuit of diagnosis and use of the treatment. The experience of symptoms and the impact of symptoms on daily life were highly variable among participants and not readily amenable to discrete categorization. Understanding particular situations is important insight to explaining adherence to CPAP.
Recognizing and acknowledging that perceived symptoms are part of a disease process and logically linked to the diagnosis of OSA was important to the participants of our study, and to their commitment to move forward from diagnosis to treatment, consistent with Engleman and Wild's findings (2003) . A recent intervention study to promote CPAP adherence incorporated specific strategies that address "personalization" of OSA symptoms (Aloia, Arnedt, Riggs, Hecht, & Borrelli, 2004; . Results of this randomized controlled trial showed lower CPAP discontinuation rates among those participants who were in the motivational enhancement and education group when compared with "usual care," suggesting the importance of assisting persons diagnosed with OSA to make the connection between the objectively measured disease/diagnosis and their lived experience of the disease . Personalizing symptoms, recognizing the impact of symptoms on daily function, and identifying the meaning of disease in terms of the perception of one's own health were clearly described by participants in our study. Adherent and nonadherent participants clearly expressed differences in their experiences of having OSA, including the impact of functional impairment on social relationships. From these differing perspectives, participants defined outcome expectations and health risks associated with OSA in different ways, possibly influencing their eventual decision to use or discontinue CPAP.
The described importance of participants' early experiences with CPAP and their initial response to CPAP treatment, both during the CPAP sleep study and during the first week of CPAP use, were influential on participants' interest in continuing to use CPAP. Our study results are consistent with Van de Mortel, Laird, and Jarrett's (2000) findings in which nonadherent, CPAP-treated OSA patients had complaints about their sleep study experience and described "major" problems on the night of their CPAP titration. Similarly, Lewis et al. (2004) found that problems identified on the first night of CPAP use, albeit on autotitrating CPAP, were consistent with lower CPAP use. Not only has the initial experience in terms of difficulties with CPAP been identified as important to subsequent CPAP adherence, but also the patient's response to the first night of CPAP (i.e., degree of sleep improvement) has been correlated with subsequent CPAP adherence (Drake et al., 2003) . The importance of promoting a positive initial experience with CPAP and providing anticipatory guidance about outcome expectations is highlighted by our findings.
The significance of social support, both proximate and within the broader social network, was an important facilitator of CPAP use among adherers in our study. Differences between the experiences of married and unmarried individuals with OSA revealed the described importance of an immediate, proximate source of support for CPAP use. Our finding is consistent with previous findings that those CPAP users who lived alone were significantly less likely to use their CPAP than those who lived with someone (Lewis et al., 2004) . Not only are immediate sources of support important for continued use of CPAP, but also shared experiences with CPAP from less-immediate social sources. Participants in our study described social relationships as motivators to seek diagnosis, providing positive reinforcement for persisting with treatment use, and a source for sharing tips on managing OSA and CPAP. Studies exploring reasons for nonadherence to antituberculosis drugs have similarly identified the importance of social influences on seeking treatment and using treatment (Naidoo, Dick, & Cooper, 2009 ). Among CPAP-treated OSA patients, intervention studies that included feedback to participants, positive reinforcement, inclusion of a support person, and assistance with trouble-shooting difficulties resulted in higher CPAP adherence among participants in the intervention groups as compared with placebo or usual-care groups (Aloia et al., 2001; Chervin, Theut, Bassetti, & Aldrich, 1997; Hoy, Vennelle, Kingshott, Engleman, & Douglas, 1999) . Confirming the applicability of these intervention strategies, the described experiences of participants in our study provide empirical support for adherence interventions that include a support person, provide early feedback and positive reinforcement to patients, and assist with trouble-shooting difficulties in the early treatment period.
Barriers to subsequent CPAP use that were identified by participants of our study included the process of having to put a mask on every night, aesthetic issues with mask/headgear use, inconvenience of having to use a machine to sleep, and daily routines that were disrupted by CPAP. Consistent with previous studies (Engleman et al., 1994; Hui et al., 2001; Massie et al., 1999; Sanders et al., 1986) , side effects of CPAP were not emphasized by participants as barriers to CPAP use. Although identified barriers did not necessitate nonadherence to CPAP in our study, it was important for individuals who experienced such barriers to identify positive reasons to use CPAP and successfully mitigate barriers, often with the help of others.
This study had several limitations. First, although the sample size of 15 was adequate for a qualitative study, there was limited power to conduct any exploratory quantitative analyses. Although not the objective of this study, quantitative exploration of commonly used measures of subjective sleepiness, functional impairment, and adherence to CPAP correlated with descriptive, quantified typologies of adherent and nonadherent CPAP users would support the findings of the study. Study participants included predominantly male veterans with severe OSA who had relatively high educational preparation. Examining this typology in a larger, more heterogeneous sample of OSA patients is needed. As the relationship of gender, disease severity, symptom perception, and disease-specific literacy with CPAP adherence has not been clearly defined, replicating this study in a more diverse sample and expanding concurrently measured quantitative outcomes would be informative and supportive of typology refinement or expansion. Finally, to reduce the potential confounding effect of clinically delivered psychoeducation, we enrolled participants referred to the study from a single clinical provider with limited participant-provider interaction at the first prediagnostic evaluation. However, participants may have had telephone contact with the sleep center staff, or had unscheduled visits at the sleep center that were not controlled for in any way in our study.
Our mixed methods, exploratory study, employing a predominantly qualitative methodology, achieved saturation of themes regarding the diagnosis of OSA and nightly CPAP use during the first week of treatment. The study results are consistent with previous studies of CPAP, even when adherence, in many previous studies, was defined as four hours/night of use rather than six hours/night of use, as in our study. With recent evidence suggesting better outcomes with longer nightly CPAP use (Stradling & Davies, 2000; Weaver et al., 2007; Zimmerman, Arnedt, Stanchina, Millman, & Aloia, 2006) , applying a definition of CPAP adherence of six hours vs. four hours likely contributed to more robust differences in described beliefs and perceptions among adherers and nonadherers. To our knowledge, the results of our study provide the first published, narrative descriptions of CPAP adherers and nonadherers that support an overall composite of characteristics that might be useful in identifying specific subgroups of patients who are most likely to benefit from tailored interventions to lessen the risk for subsequent CPAP nonadherence. To date, studies have provided adherence promotion interventions to unselected groups, possibly minimizing variation of response between intervention and control groups. Future randomized controlled trials testing CPAP adherence interventions delivered to participants who are selected based on their risk for treatment failure because of nonadherence are necessary to evaluate intervention effectiveness.
